OneAscent Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
38,388
+23,640
+160% +$629K 0.06% 206
2025
Q4
$367K Buy
14,748
+207
+1% +$5.22K 0.03% 306
2025
Q3
$371K Sell
14,541
-23,165
-61% -$572K 0.05% 268
2025
Q2
$933K Sell
37,706
-40,774
-52% -$951K 0.07% 187
2025
Q1
$1.95M Buy
78,480
+41,481
+112% +$1.09M 0.13% 115
2024
Q4
$982K Buy
36,999
+11,447
+45% +$310K 0.08% 158
2024
Q3
$739K Buy
+25,552
New +$745K 0.53% 46
2024
Q2
Sell
-23,395
Closed -$649K 341
2024
Q1
$649K Sell
23,395
-1,231
-5% -$34.2K 0.07% 168
2023
Q4
$709K Buy
+24,626
New +$744K 0.09% 150
2022
Q4
Sell
-6,243
Closed -$273K 227
2022
Q3
$273K Sell
6,243
-322
-5% -$15.6K 0.11% 135
2022
Q2
$344K Buy
+6,565
New +$335K 0.16% 126
2019
Q3
Sell
-11,570
Closed -$476K 143
2019
Q2
$476K Buy
+11,570
New +$459K 0.33% 53

Other funds holding PFE

OneAscent Financial Services's PFE Position: Q1 2026 in Review

OneAscent Financial Services increased its Pfizer (PFE) stake by 160% in Q1 2026, buying an estimated $629K and bringing the position to 38,388 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #206.

OneAscent Financial Services first reported a position in PFE in Q2 2019 and has held it in 12 quarters since. The position peaked at $1.95M in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • OneAscent Financial Services held 38,388 shares of Pfizer worth $1.08M as of Q1 2026.
  • OneAscent Financial Services bought 23,640 Pfizer shares in Q1 2026, an estimated $629K.
  • Pfizer made up 0.06% of OneAscent Financial Services's portfolio in Q1 2026, its #206 holding.
  • OneAscent Financial Services first reported a position in Pfizer in Q2 2019 and has held it in 12 quarters since.
  • OneAscent Financial Services's Pfizer position peaked at $1.95M in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on OneAscent Financial Services's 13F filing for Q1 2026, filed 21 Apr 2026.